Read More

XPeng Fears Tariff Hike In Europe, Reportedly Considers Investing Abroad

As the European Commission investigates Chinese EVs, XPeng weighs overseas production options amidst regulatory adjustments. Brian Gu, co-president of Volkswagen-backed XPeng, reports potential shifts in strategy amid evolving regulations. With eyes on a 10% international sales boost, XPeng targets US market entry despite challenges.

VWAGY

Read More

Honda’s Bet On Canadian EV Hub: Reportedly Plans $11B Investment

Honda Motor reportedly announces a groundbreaking $11 billion investment to pioneer electric vehicle manufacturing in Canada. Collaborating with Canadian authorities, this strategic move signifies Honda's commitment to meeting the rising demand for electric vehicles in North America. The decision underscores a significant milestone for Canada's emergence as a pivotal player in the regional electric vehicle market.

AVDE

Read More

Struggle For Hertz Continues As Stock Loses 23% – Here’s Why

Hertz Global Holdings faces a dip in shares post-reporting a 1.6% sales uptick to $2.04 billion in Q1 FY24, slightly exceeding forecasts. Despite a 10% rise in average rentable vehicles, challenges persist with a 7% decline in total revenue per day (RPD). CEO Gil West attributes the performance setback to fleet and direct operating costs, highlighting areas for potential improvement.

HTZ

Read More

Tiziana Life Sciences Reports 3-Month Neuroimaging Scores In Multiple Sclerosis Patients Receiving Intranasal Foralumab; A Primary Endpoint With Clinical Measures Of EDSS (Disability) And MFIS (Fatigue) Is Currently Underway

Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced for the first time,

TLSA